BIGG DIGITAL ASSETS INC
BBKCF
Abits
ABTS
Ebang International
EBON
Bakkt Holdings
BKKT
Mawson Infrastructure
MIGI
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.